Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.

Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group.

Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280. Epub 2013 May 28.

PMID:
23714399
[PubMed - indexed for MEDLINE]
Free Article
2.

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Saliba F, Jonas S, Sudan D, Fung J, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Witte S, Jiang H, Hexham JM, Junge G; H2304 Study Group.

Am J Transplant. 2012 Nov;12(11):3008-20. doi: 10.1111/j.1600-6143.2012.04212.x. Epub 2012 Aug 6.

PMID:
22882750
[PubMed - indexed for MEDLINE]
Free PMC Article

Supplemental Content

Loading ...
Write to the Help Desk